Medline ® Abstract for Reference 91
of 'Clinical features, diagnosis, and management of von Hippel-Lindau disease'
Outcome of twin babies free of Von Hippel-Lindau disease after a double-factor preimplantation genetic diagnosis: monogenetic mutation analysis and comprehensive aneuploidy screening.
Obradors A, Fernández E, Rius M, Oliver-Bonet M, Martínez-Fresno M, Benet J, Navarro J
Fertil Steril. 2009;91(3):933.e1. Epub 2009 Jan 10.
OBJECTIVE: To increase the embryo implantation rate, a double-factor preimplantation genetic diagnosis (DF-PGD) was performed, selecting for transfer potentially euploid evolved embryos free of the mutation responsible for Von Hippel-Lindau syndrome (VHL).
DESIGN: Case report.
SETTINGS: Medical university center and a private IVF center.
PATIENT(S): A patient carrier of the R161Q mutation on the VHL gene.
INTERVENTION(S): After first polar body (1PB) biopsy, it was analyzed using comparative genomic hybridization (1PB-CGH). On day +3, mutation detection using minisequencing and short tandem repeat analysis was performed in multiple displacement amplification products of a single blastomere per embryo.
MAIN OUTCOME MEASURE(S): Transfering embryos free of the disease and originating from euploid oocytes.
RESULT(S): Nine of the twelve oocytes obtained were successfully analyzed using 1PB-CGH. One of them was aneuploid (1PB #1: 29XX,+2,+10,+12,+17,+19), and the rest were euploid. All of the oocytes were fertilized and became evolved embryos. Six of the embryos were VHL unaffected and had good quality. Five (83%) of them were potentially euploid. According to cytogenetic results, two of the evolved and healthy embryos were transfered, achieving the birth of healthy twin babies.
CONCLUSION(S): The DF-PGD can be a useful tool to increase implantation of transfered embryos in PGD for monogenic diseases.
Unitat de Biologia Cellular i Genètica Mèdica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. firstname.lastname@example.org